JCR 2024 Program
-
33. JCR-CBS-CHIP Session (JCR-Nanjing Joint Session)
Room D : 09:00~10:30
-
27. Abstract Competition Session
Room D : 11:00~12:10
-
37. Sponsored Scientific Luncheon: Management of Angina in Clinical Practice (Sponsored by Mitsubishi Tanabe Pharma Korea)
Room D : 12:30~13:30
-
28. Case Competition Session
Room D : 15:20~16:20
33. JCR-CBS-CHIP Session (JCR-Nanjing Joint Session)
Room D : 09:00~10:30
Chair
Moo Hyun Kim, Jong-Seon Park, Jun-Jie ZhangPanel
Bill D. Gogas, Nailiang Tian, Song Lin, Zhen Ge, Jeong Cheon Choe, Yu Chen WangSpeaker
09:00-09:15 |
IVUS ACS Trial – Evidence and Clinical cases
Zhen Ge |
09:15-09:30 |
IVUS-guided CTO bifurcation PCI
Janghoon Lee |
09:30-09:45 |
ULTIMATE 3 trial: Evidence and Clinical Case
Jun-Jie Zhang |
09:45-10:00 |
ECMO support – Evidence and Clinical Case
Nailiang Tian |
10:00-10:15 |
Challenging CHIP PCI cases
Duk-Woo Park |
27. Abstract Competition Session
Room D : 11:00~12:10
Chair
Tae Hoon Ahn, Seung Uk Lee, Lee FarrandPanel
Jae Sik Jang, Kyoung hoon Lee, Sea-Won Lee, Sung-Cheol Yun, Jong Kwan ParkSpeaker
11:00-11:10 |
The Relationship of Atorvastatin Plasma Levels with Doses Prescribed in Patients with Acute Myocardial Infarction
Gerald Grino Anak Apil |
11:10-11:20 |
Next Generation Korean BRS from Dotter
Eun Jung Jun |
11:20-11:30 |
Long-term aspirin vs clopidogrel after coronary stenting by bleeding risk and procedural complexity
Jaewook Chung |
11:30-11:40 |
Enhanced Clinical Benefit of Preventive PCI of Vulnerable Coronary Plaques in Patients With Concomitant Non-Target Vessel PCI: A Prespecified Subgroup Analysis of the PREVENT Trial
Soo Yeon An |
11:40-11:50 |
Clinical outcomes in patients on SGLT2 inhibitor therapy in PCI patients with AMI: from multi center AMI registry
Kwanho Nam |
11:50-12:00 |
Sex differences in clinical data and long-term outcomes of elderly patients with acute myocardial infarction presenting with cardiogenic shock undergoing percutaneous coronary intervention
Jeong Cheon Choe |
37. Sponsored Scientific Luncheon: Management of Angina in Clinical Practice (Sponsored by Mitsubishi Tanabe Pharma Korea)
Room D : 12:30~13:30
Chair
Dong Woon JeonPanel
Sea-Won Lee, Bowon Kim, Jong Sung ParkSpeaker
12:35-12:55 |
Treatment of Vasospastic angina with Diltiazem
Seung-Woon Rha |
12:55-13:15 |
Treatment option for angina with Coronary Microvascular Dysfunction (CMD)
Jong Kwan Park |
28. Case Competition Session
Room D : 15:20~16:20
Chair
Jinyong Hwang, Jong-Seon ParkPanel
Hyuck Jun Yoon, Masaaki OkutsuSpeaker
15:20-15:30 |
Short Term Outcomes of Novel IVL Technology in Treatment of Calcified CAD in Patients with End Stage Renal Failure
Chen Ting Tan |
15:30-15:40 |
A case of endovascular treatment of popliteal artery occlusion with severe calcification
Byung-Jun Kim |
15:40-15:50 |
Successful Re-wiring Using Sasuke Microcatheter After Dissection Following Pre-balloon Dilatation of Heavily Calcified Lesion in pRCA in a 65-year-old Male with Unstable Angina
Dong-Hwan Ku |
15:50-16:00 |
Acute profound thrombocytopenia after use of GPIIb/IIIa receptor antagonist
Yeonwoo Choi |
16:00-16:10 |
Refractory popliteal artery and BTK thrombotic occlusion: How to finalize?
Seung-Woon Rha |